_version_ 1784883222762487808
author Dreger, Peter
Holtick, Udo
Subklewe, Marion
von Tresckow, Bastian
Ayuk, Francis
Wagner, Eva
Wulf, Gerald
Marks, Reinhardt
Penack, Olaf
Schnetzke, Ulf
Koenecke, Christian
von Bonin, Malte
Stelljes, Matthias
Glass, Bertram
Baldus, Claudia D.
Vucinic, Vladan
Mougiakakos, Dimitrios
Topp, Max
Schroers, Roland
Wolff, Daniel
Thomas, Simone
Kröger, Nicolaus
Bethge, Wolfgang A.
author_facet Dreger, Peter
Holtick, Udo
Subklewe, Marion
von Tresckow, Bastian
Ayuk, Francis
Wagner, Eva
Wulf, Gerald
Marks, Reinhardt
Penack, Olaf
Schnetzke, Ulf
Koenecke, Christian
von Bonin, Malte
Stelljes, Matthias
Glass, Bertram
Baldus, Claudia D.
Vucinic, Vladan
Mougiakakos, Dimitrios
Topp, Max
Schroers, Roland
Wolff, Daniel
Thomas, Simone
Kröger, Nicolaus
Bethge, Wolfgang A.
author_sort Dreger, Peter
collection PubMed
description
format Online
Article
Text
id pubmed-9902271
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99022712023-02-08 Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience Dreger, Peter Holtick, Udo Subklewe, Marion von Tresckow, Bastian Ayuk, Francis Wagner, Eva Wulf, Gerald Marks, Reinhardt Penack, Olaf Schnetzke, Ulf Koenecke, Christian von Bonin, Malte Stelljes, Matthias Glass, Bertram Baldus, Claudia D. Vucinic, Vladan Mougiakakos, Dimitrios Topp, Max Schroers, Roland Wolff, Daniel Thomas, Simone Kröger, Nicolaus Bethge, Wolfgang A. Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-11-22 2023 /pmc/articles/PMC9902271/ /pubmed/36418916 http://dx.doi.org/10.1038/s41409-022-01867-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Dreger, Peter
Holtick, Udo
Subklewe, Marion
von Tresckow, Bastian
Ayuk, Francis
Wagner, Eva
Wulf, Gerald
Marks, Reinhardt
Penack, Olaf
Schnetzke, Ulf
Koenecke, Christian
von Bonin, Malte
Stelljes, Matthias
Glass, Bertram
Baldus, Claudia D.
Vucinic, Vladan
Mougiakakos, Dimitrios
Topp, Max
Schroers, Roland
Wolff, Daniel
Thomas, Simone
Kröger, Nicolaus
Bethge, Wolfgang A.
Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
title Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
title_full Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
title_fullStr Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
title_full_unstemmed Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
title_short Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience
title_sort impact of age on outcome of car-t cell therapies for large b-cell lymphoma: the gla/drst experience
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902271/
https://www.ncbi.nlm.nih.gov/pubmed/36418916
http://dx.doi.org/10.1038/s41409-022-01867-4
work_keys_str_mv AT dregerpeter impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT holtickudo impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT subklewemarion impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT vontresckowbastian impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT ayukfrancis impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT wagnereva impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT wulfgerald impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT marksreinhardt impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT penackolaf impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT schnetzkeulf impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT koeneckechristian impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT vonboninmalte impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT stelljesmatthias impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT glassbertram impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT baldusclaudiad impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT vucinicvladan impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT mougiakakosdimitrios impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT toppmax impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT schroersroland impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT wolffdaniel impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT thomassimone impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT krogernicolaus impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT bethgewolfganga impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience
AT impactofageonoutcomeofcartcelltherapiesforlargebcelllymphomathegladrstexperience